News
![Synalloy Announces Commencement of Rights Offering](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Synalloy Announces Commencement of Rights Offering
Synalloy Corporation (Nasdaq: SYNL) (“Synalloy” or the “Company”), an industrials company focused on the production and distribution of piping, tubing and specialty chemicals, today announced that
![ImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development Program: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeWtBVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--000b3982bf8e90eb30a01cca9649be03b0baae66/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ImmunoPrecise_logo_HZ_PMS.jpg?locale=us)
ImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development Program
IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) is providing an update on its Polytope™ Development Program. The Company continues to rapidly progress it
![DGAP-News: LPKF Opens Biolab for ARRALYZE Technologyhttp://upload.wikimedia.org/wikipedia/de/f/f2/Logo_LPKF_Laser_%26_Electronics.svg: LPKF LASER+ELECTRONICS](https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemJ3VlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9e2641b1cd4edc6fa09c1a96726eeeceef6066dc/Logo_LPKF_Laser_&_Electronics.svg.png?locale=us)
DGAP-News: LPKF Opens Biolab for ARRALYZE Technology
![Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdEVCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--1b3c47f309e54c35ff476143bba270ac36f5bc61/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Symantec.jpg?locale=us)
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
![IMV Announces First Patient Dosed in Phase 1b Clinical Study Evaluating its Lead Compound in Patients with Breast Cancer: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenlNSlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--44b7c2e9ec1d34b6817ce17f4c733565e4a558a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/IMV_Logos_IMV-Logo_BrandStatement.jpg?locale=us)
IMV Announces First Patient Dosed in Phase 1b Clinical Study Evaluating its Lead Compound in Patients with Breast Cancer
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and blood cancers while preserving
![Nickel 28 Files Q3 2021 Financial Statements: https://mms.businesswire.com/media/20210315005235/en/865031/5/Nickel28Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM280Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b0dcd3c2569e1cfefe175b199a2e69d1e39ab624/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nickel28Logo.jpg?locale=us)
Nickel 28 Files Q3 2021 Financial Statements
Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC0) has released its results for the three and nine-months ended September 30, 2021.
“Following a strong H1 2021
![NICE Customer Journey Analytics Recognized for Technology Excellence and Customer Impact Driven by Leadership in AI: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtvRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--06f22a0c3a8fabdec4f231cf3ebdea0279feec53/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/NICE_inContact.jpg?locale=us)
NICE Customer Journey Analytics Recognized for Technology Excellence and Customer Impact Driven by Leadership in AI
NICE (Nasdaq: NICE) today announced that it has been recognized as a Technology Leader by Quadrant Knowledge Solutions. The global advisory and consulting firm’s SPARK Matrix™: Customer Journey
![RRD Confirms Receipt of Revised Proposal from Chatham Asset Management](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
RRD Confirms Receipt of Revised Proposal from Chatham Asset Management
R.R. Donnelley & Sons Company (NYSE: RRD) (“RRD” or the “Company”) today announced that it has received a proposal from Chatham Asset Management, LLC ("Chatham") to acquire all of the outstanding
![Perion’s Black Friday eCommerce Search Volume Breaks Previous Record, Despite Overall Online Sales Dip: https://mms.businesswire.com/media/20191107005494/en/755179/5/Perion_triangles_%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtpRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2a30bf1ed7de56ca36e10b3ea5624afd5483c532/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Perion_triangles_-28002-29.jpg?locale=us)
Perion’s Black Friday eCommerce Search Volume Breaks Previous Record, Despite Overall Online Sales Dip
Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers a holistic solution across the three main pillars of digital advertising – ad search, social media, and
DGAP-News: Schaeffler AG: Schaeffler Group celebrates company anniversary - in motion for the last 75 years
![EVO Payments and Bank of Ireland Renew Exclusive Alliance Agreement for Merchant Acquiring and Payment Processing Services](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
EVO Payments and Bank of Ireland Renew Exclusive Alliance Agreement for Merchant Acquiring and Payment Processing Services
EVO Payments, Inc. (NASDAQ: EVOP) (“EVO”), a leading global provider of payment technology integrations and acquiring solutions, and Bank of Ireland Group (“Bank of Ireland”), one of the largest
DGAP-News: Steinhoff International Holdings N.V. : DISCLOSURE OF DIRECTOR'S SHAREHOLDING NOTIFICATION
![Omba Investments ICAV Names Northern Trust as Asset Servicing Provider for New Fund: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24662/Northern_trust_logo16.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZ2tCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--17d40a80eb282cbe2ad4f4a19868097bc48df967/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Northern_trust_logo16.png?locale=us)
Omba Investments ICAV Names Northern Trust as Asset Servicing Provider for New Fund
Northern Trust (Nasdaq: NTRS) has been appointed by Omba Investments Irish Collective Asset-management Vehicle (ICAV) to provide global custody, depositary and associated services for its new
![Expro Wins Over $50 Million in Subsea Well Contracts for Asia/Australia: https://mms.businesswire.com/media/20211004005944/en/1182225/5/Expro_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMmcvVnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--145eb40f03830c2c8a927db639a83f62e4e72a02/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Expro_Logo.jpg?locale=us)
Expro Wins Over $50 Million in Subsea Well Contracts for Asia/Australia
Leading provider of energy services, Expro (NYSE: XPRO), has secured four significant subsea well access contracts in South East Asia and Australia worth in excess of $50 million.
The company has
Heidelberger Druckmaschinen AG: Heidelberg commits to becoming climate neutral by 2030
![DGAP-News: Rubean AG: Rubean AG stronger positioned with CCV suboperation: https://mms.businesswire.com/media/20210519005054/en/879386/5/rubean.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeW1QVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9be84986b5d895c9e84a46f46424f8141f1f4d94/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/rubean.jpg?locale=us)
DGAP-News: Rubean AG: Rubean AG stronger positioned with CCV suboperation
![GenSight Biologics to Host Key Opinion Leader Webcast on Outcomes Among Compassionate Use Patients Treated Bilaterally with LUMEVOQ® in the US: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXBqRmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--32e5498581c41f5af17897302b60481289223182/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Logo+Centre+Hospitalier+XV-XX.jpg?locale=us)
GenSight Biologics to Host Key Opinion Leader Webcast on Outcomes Among Compassionate Use Patients Treated Bilaterally with LUMEVOQ® in the US
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
![Vifor Pharma announces changes to the Executive Committee as CFO retires: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMndsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--37beee983e668f5de331d0d69e2c6f07f1240d69/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/VP_logo_rgb.jpg?locale=us)
Vifor Pharma announces changes to the Executive Committee as CFO retires
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma Group today announced that Colin Bond, Chief Financial Officer will retire from the company by the end of December 2021
DGAP-News: Nordex SE: Nordex Group receives another order in Brazil from AES Brasil for 370 MW
DGAP-News: Biotest AG: Biotest receives approval for Intratect(R) in France
![Lomiko Metals Provides Update on its Circular and Announces Release of Year-End Financials: https://mms.businesswire.com/media/20210312005102/en/864833/5/LomikoLogo%28horizontal-colour%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMm8yVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b227a80ff15db7af463ab5c7bed9389990f976d9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LomikoLogo-28horizontal-colour-29.jpg?locale=us)
Lomiko Metals Provides Update on its Circular and Announces Release of Year-End Financials
Lomiko Metals Inc. (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) ("Lomiko Metals” or the “Company”) announces that further to its management information circular dated November 4, 2021 and filed on SEDAR
![GAMCO Announces $0.50 Per Share Shareholder Designated Charitable Contribution: https://mms.businesswire.com/media/20201019005535/en/831358/5/CBS+logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN0J4VlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--83978139d6ec6901ce8d33cbf2d2a6b5537b2f27/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/CBS+logo.jpg?locale=us)
GAMCO Announces $0.50 Per Share Shareholder Designated Charitable Contribution
GAMCO Investors, Inc. (“GAMCO”) (NYSE: GBL) announced today that its Board of Directors approved a $0.50 per share shareholder designated charitable contribution (“SDCC”). This brings the total
![Blue Bird Corporation Announces Amendment of Credit Facility: https://mms.businesswire.com/media/20210323005889/en/866918/5/Nuvve+%281%29+%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOXBDVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c5b16db91a1bf6d6bfe6c63b355a012accefdc15/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Nuvve+-281-29+-28002-29.jpg?locale=us)
Blue Bird Corporation Announces Amendment of Credit Facility
Today, Blue Bird Corporation (NASDAQ: BLBD), a leading manufacturer of school and activity buses, announced that it entered into a fourth amendment to its credit facility, dated as of December 12
![Owens & Minor to Present at Bank of America Leveraged Finance Conference: https://mms.businesswire.com/media/20211103005246/en/922805/5/O%26M_LogoTM_hi-res.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBelZxVnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c6152a10270251b9031301fd12cb22d02d22a1b1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/O-26M_LogoTM_hi-res.jpg?locale=us)
Owens & Minor to Present at Bank of America Leveraged Finance Conference
Owens & Minor, Inc. (NYSE-OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, today announced that Andy